Cargando…
Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity
AIM: Obesity is a disease complicating the course of COVID-19 and SARS-CoV-2 vaccine effectiveness in adults with obesity may be compromised. Our aim is to investigate the spike-protein receptor-binding domain antibody titers against BNT162b2 mRNA and inactivated SARS-CoV-2 (CoronaVac) vaccines in p...
Autores principales: | Kara, Zehra, Akçin, Rüveyda, Demir, Ahmet Numan, Dinç, Harika Öykü, Taşkın, Halit Eren, Kocazeybek, Bekir, Yumuk, Volkan Demirhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263798/ https://www.ncbi.nlm.nih.gov/pubmed/35802279 http://dx.doi.org/10.1007/s11695-022-06181-y |
Ejemplares similares
-
Risk Factors Influencing Seroconversion after Inactive SARS-CoV-2 Vaccination in People Living with Obesity
por: Kara, Zehra, et al.
Publicado: (2022) -
Antibody Response to Inactive SARS-CoV-2 Vaccination in a Cohort of Elderly Patients Living with Obesity
por: Kara, Zehra, et al.
Publicado: (2023) -
Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study
por: Dinç, Harika Öykü, et al.
Publicado: (2022) -
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period
por: Atahan, Ersan, et al.
Publicado: (2022) -
Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis
por: Atahan, Ersan, et al.
Publicado: (2023)